Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

Patients with myeloid neoplasms who relapsed after allogenic hematopoietic stem cell transplant (HSCT) have poor prognosis. Monitoring of chimerism and specific molecular markers as a surrogate measure of relapse is not always helpful; therefore, improved systems to detect early relapse are needed....

Descripción completa

Detalles Bibliográficos
Autores principales: Aguirre-Ruiz, Paula, Ariceta, Beñat, Viguria, María Cruz, Zudaire, María Teresa, Blasco-Iturri, Zuriñe, Arnedo, Patricia, Aguilera-Diaz, Almudena, Jauregui, Axier, Mañú, Amagoia, Prosper, Felipe, Mateos, María Carmen, Fernández-Mercado, Marta, Larráyoz, María José, Redondo, Margarita, Calasanz, María José, Vázquez, Iria, Bandrés, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760908/
https://www.ncbi.nlm.nih.gov/pubmed/33255857
http://dx.doi.org/10.3390/jcm9123818

Ejemplares similares

Ejemplares similares